세계의 나노바이오테크놀로지 시장 조사 및 예측 : 제품별, 용도별, 기술별, 최종 용도별, 지역별 분석(2023-2030년)

Global Nanobiotechnology Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Nanobiotechnology is a multidisciplinary field that combines nanotechnology and biology to develop novel tools, techniques, and materials for biological and medical applications. It involves the use of nanoscale materials, such as nanoparticles, nanotubes, and nanofibers, for various biological and medical purposes, including drug delivery, imaging, diagnostics, and biosensing. Nanobiotechnology is aimed at developing innovative solutions to address various challenges in healthcare, agriculture, environment, and other industries by harnessing the unique properties of nanoscale materials. The major driving factors for the Global Nanobiotechnology Market are increasing demand for advanced diagnostics and therapeutics and rising investments in R&D. Moreover, growing applications in drug delivery and increasing focus on personalized medicine are creating lucrative growth opportunities for the market over the forecast period 2023-2030.

Governments and private organizations are investing heavily in nanobiotechnology R&D, leading to the development of new technologies and products. These investments are driving the growth of the nanobiotechnology market by creating new opportunities for the development of innovative products and solutions. For instance, in November 2020, researchers at the University of Cambridge developed a new type of sensor using nanotechnology that can detect the presence of COVID-19 in wastewater before the virus spreads to the population. Along with this, in March 2021, scientists at the University of Manchester developed a new nanotechnology-based treatment for cancer that uses tiny particles called "quantum dots" to destroy cancer cells. Furthermore, in May 2021, researchers at the University of California developed a new type of nanotechnology-based vaccine that can be used against multiple strains of the flu virus. However, the high cost of Nanobiotechnology stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Nanobiotechnology Market study include: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the nanobiotechnology market in 2020, owing to the presence of established market players, well-developed healthcare infrastructure, and increasing government funding for nanobiotechnology research. The United States is the largest contributor to the nanobiotechnology market in this region. The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period, due to the rising investments in R&D activities, increasing healthcare expenditure, and the growing demand for advanced diagnostic and therapeutic technologies. China, Japan, and India are the major contributors to the nanobiotechnology market in this region.

Major market players included in this report are:

• Thermo Fisher Scientific Inc.
• Abcam plc
• GenScript Biotech Corporation
• NanoTemper Technologies GmbH
• Agilent Technologies, Inc.
• Bruker Corporation
• Bio-Rad Laboratories, Inc.
• PerkinElmer, Inc.
• Nanosens Innovations
• AstraZeneca plc

Recent Developments in the Market:

• In 2021, Thermo Fisher Scientific launched the Applied Biosystems Axiom Microbiome Array, a genotyping tool for the detection and analysis of microbiomes. This array uses nanobiotechnology to identify and analyze microbial communities in human, animal, and environmental samples.

Global Nanobiotechnology Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimation: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Product, Application, Technology, End-use, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

• Nanobiotechnology instruments
• Nanobiotechnology services
• Nanobiotechnology products

By Application:

• Drug Delivery
• Genomics
• Proteomics
• Diagnostics
• Others

By Technology:

• Nanoparticles
• Nanotubes
• Nanoshells
• Others

By End-use:

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Diagnostic Laboratories
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Nanobiotechnology Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Nanobiotechnology Market, by Product, 2020-2030 (USD Billion)
  • 1.2.3. Nanobiotechnology Market, by Application, 2020-2030 (USD Billion)
  • 1.2.4. Nanobiotechnology Market, by Technology, 2020-2030 (USD Billion)
  • 1.2.5. Nanobiotechnology Market, by End-use, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Nanobiotechnology Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Nanobiotechnology Market Dynamics

• 3.1. Nanobiotechnology Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing demand for advanced diagnostics and therapeutics
    • 3.1.1.2. Rising investments in R&D
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Nanobiotechnology
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing applications in drug delivery
    • 3.1.3.2. Increasing focus on personalized medicine

Chapter 4. Global Nanobiotechnology Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Nanobiotechnology Market, by Product

• 5.1. Market Snapshot
• 5.2. Global Nanobiotechnology Market by Product, Performance - Potential Analysis
• 5.3. Global Nanobiotechnology Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
• 5.4. Nanobiotechnology Market, Sub Segment Analysis
  • 5.4.1. Nanobiotechnology instruments
  • 5.4.2. Nanobiotechnology services
  • 5.4.3. Nanobiotechnology products

Chapter 6. Global Nanobiotechnology Market, by Application

• 6.1. Market Snapshot
• 6.2. Global Nanobiotechnology Market by Application, Performance - Potential Analysis
• 6.3. Global Nanobiotechnology Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4. Nanobiotechnology Market, Sub Segment Analysis
  • 6.4.1. Drug Delivery
  • 6.4.2. Genomics
  • 6.4.3. Proteomics
  • 6.4.4. Diagnostics
  • 6.4.5. Others

Chapter 7. Global Nanobiotechnology Market, by Technology

• 7.1. Market Snapshot
• 7.2. Global Nanobiotechnology Market by Technology, Performance - Potential Analysis
• 7.3. Global Nanobiotechnology Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
• 7.4. Nanobiotechnology Market, Sub Segment Analysis
  • 7.4.1. Nanoparticles
  • 7.4.2. Nanotubes
  • 7.4.3. Nanoshells
  • 7.4.4. Others

Chapter 8. Global Nanobiotechnology Market, by End-use

• 8.1. Market Snapshot
• 8.2. Global Nanobiotechnology Market by End-use, Performance - Potential Analysis
• 8.3. Global Nanobiotechnology Market Estimates & Forecasts by End-use 2020-2030 (USD Billion)
• 8.4. Nanobiotechnology Market, Sub Segment Analysis
  • 8.4.1. Pharmaceutical and Biotechnology Companies
  • 8.4.2. Academic and Research Institutes
  • 8.4.3. Diagnostic Laboratories
  • 8.4.4. Others

Chapter 9. Global Nanobiotechnology Market, Regional Analysis

• 9.1. Top Leading Countries
• 9.2. Top Emerging Countries
• 9.3. Nanobiotechnology Market, Regional Market Snapshot
• 9.4. North America Nanobiotechnology Market
  • 9.4.1. U.S. Nanobiotechnology Market
    • 9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
    • 9.4.1.2. Application breakdown estimates & forecasts, 2020-2030
    • 9.4.1.3. Technology breakdown estimates & forecasts, 2020-2030
    • 9.4.1.4. End-use breakdown estimates & forecasts, 2020-2030
  • 9.4.2. Canada Nanobiotechnology Market
• 9.5. Europe Nanobiotechnology Market Snapshot
  • 9.5.1. U.K. Nanobiotechnology Market
  • 9.5.2. Germany Nanobiotechnology Market
  • 9.5.3. France Nanobiotechnology Market
  • 9.5.4. Spain Nanobiotechnology Market
  • 9.5.5. Italy Nanobiotechnology Market
  • 9.5.6. Rest of Europe Nanobiotechnology Market
• 9.6. Asia-Pacific Nanobiotechnology Market Snapshot
  • 9.6.1. China Nanobiotechnology Market
  • 9.6.2. India Nanobiotechnology Market
  • 9.6.3. Japan Nanobiotechnology Market
  • 9.6.4. Australia Nanobiotechnology Market
  • 9.6.5. South Korea Nanobiotechnology Market
  • 9.6.6. Rest of Asia Pacific Nanobiotechnology Market
• 9.7. Latin America Nanobiotechnology Market Snapshot
  • 9.7.1. Brazil Nanobiotechnology Market
  • 9.7.2. Mexico Nanobiotechnology Market
• 9.8. Middle East & Africa Nanobiotechnology Market
  • 9.8.1. Saudi Arabia Nanobiotechnology Market
  • 9.8.2. South Africa Nanobiotechnology Market
  • 9.8.3. Rest of Middle East & Africa Nanobiotechnology Market

Chapter 10. Competitive Intelligence

• 10.1. Key Company SWOT Analysis
  • 10.1.1. Company 1
  • 10.1.2. Company 2
  • 10.1.3. Company 3
• 10.2. Top Market Strategies
• 10.3. Company Profiles
  • 10.3.1. Thermo Fisher Scientific Inc.
    • 10.3.1.1. Key Information
    • 10.3.1.2. Overview
    • 10.3.1.3. Financial (Subject to Data Availability)
    • 10.3.1.4. Product Summary
    • 10.3.1.5. Recent Developments
  • 10.3.2. Abcam plc
  • 10.3.3. GenScript Biotech Corporation
  • 10.3.4. NanoTemper Technologies GmbH
  • 10.3.5. Agilent Technologies, Inc.
  • 10.3.6. Bruker Corporation
  • 10.3.7. Bio-Rad Laboratories, Inc.
  • 10.3.8. PerkinElmer, Inc.
  • 10.3.9. Nanosens Innovations
  • 10.3.10. AstraZeneca plc

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption